United States· US:0270-5264_42adc803-ceea-22aa-459c-f8617b2d8e56
MultiHance
A medicinal product containing gadobenate dimeglumine, registered in United States by BRACCO DIAGNOSTICS INC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- GADOBENATE DIMEGLUMINE
- Manufacturer
- BRACCO DIAGNOSTICS INC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1102705264165 BOTTLE, GLASS in 1 BOX (0270-5264-16) / 50 mL in 1 BOTTLE, GLASS
- ndc1102705264175 BOTTLE, GLASS in 1 BOX (0270-5264-17) / 100 mL in 1 BOTTLE, GLASS
- ndc110270-5264-16
- ndc110270-5264-17
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Gadobenate dimeglumine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandMultiHance 529 mg/ml solution for injection in pre-filled syringeBracco Imaging spa
- CzechiaMULTIHANCEBracco Imaging Deutschland GmbH, Konstanz
- BelgiumMultihance 0.5 mmol/mlBracco Imaging Deutschland
- United KingdomMultiHance 0.5mmol/ml solution for injection 10ml vialsBracco UK Ltd
- FranceMULTIHANCE 0,5 mmol/mL, solution injectable (IV)BRACCO IMAGING FRANCE
- GermanyMultihanceEurocontrast Gmbh
- SwedenMultiHance 334 mg/ml Injektionsvätska, lösningBracco Imaging SpA
- NorwayMultiHanceBracco Imaging SpA
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Multihance
- Belgium · Multihance
- Czechia · Multihance
- Germany · Multihance
- Denmark · Multihance
- Spain · Multihance
- Finland · Multihance
- France · Multihance
- United Kingdom (Northern Ireland) · Multihance
- Greece · Multihance
- Croatia · Multihance
- Hungary · Multihance
- Ireland · Multihance
- Italy · Multihance
- Luxembourg · Multihance
- Netherlands · Multihance
- Norway · Multihance
- Poland · Multihance
- Portugal · Multihance
- Romania · Multihance
- Sweden · Multihance
- Slovenia · Multihance
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/20c92f62-2c24-4b74-b48f-4c25850f4cc2 GET /v1/drugs/20c92f62-2c24-4b74-b48f-4c25850f4cc2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "529",
"substance": "GADOBENATE DIMEGLUMINE",
"productndc": "0270-5264",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA021358",
"marketing_category": "NDA"
}See everything about gadobenate dimeglumine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.